Table 3

Presenting symptoms and proctoscopic findings in rectal LGV cases and symptomatic controls

CharacteristicCases
n (%)
Controls
n (%)
OR (95% CI)p Value
Total9881
Any rectal symptoms89 (91)81 (100)n/a
Duration: median days (IQR)13 (5–21)7 (3.5–14.5)n/a0.146*
Anal discharge65 (66)36 (44)2.46 (1.34 to 4.51)0.004
Rectal bleeding60 (61)41 (51)1.54 (0.85 to 2.79)0.155
Anal pain55 (56)36 (44)1.60 (0.88 to 2.89)0.121
Tenesmus32 (33)6 (7)6.06 (2.39 to 15.40)<0.001
Constipation29 (30)8 (10)3.84 (1.64 to 8.96)0.002
Loose stools/diarrhoea28 (29)20 (25)1.22 (0.63 to 2.38)0.560
Any constitutional symptoms33 (34)21 (26)1.45 (0.76 to 2.78)0.265
Malaise19 (20)8 (10)2.19 (0.90 to 5.32)0.082
Fever16 (16)8 (10)1.78 (0.72 to 4.40)0.213
Weight loss11 (11)1 (1)10.10 (1.28 to 80.06)0.029
Any genital or inguinal symptoms11 (11)12 (15)0.73 (0.30 to 1.75)0.476
Proctoscopy findings81 (91)73 (91)
Normal8 (10)16 (22)0.39 (0.16 to 0.97)0.044
Proctitis52 (65)34 (47)2.08 (1.08 to 3.98)0.028
Rectal bleeding31 (39)13 (18)2.87 (1.36 to 6.08)0.006
Exudate47 (59)20 (28)3.70 (1.87 to 7.32)<0.001
Lesion or/ulcer13 (16)10 (14)1.22 (0.50 to 3.00)0.661
  • *Wilcoxon rank sum test for medians.

  • †Proctoscopy was not performed in 17 cases (9 asymptomatic, 1 unable to be performed because of pain, 2 had perianal lesions only, 1 declined, 4 reason not recorded) and 8 controls (2 because of pain, 3 perianal lesions, 1 abdominal cramps, 2 reason not recorded).

  • LGV, lymphogranuloma venereum.